Literature DB >> 18337407

Nicotine self-administration differentially regulates hypothalamic corticotropin-releasing factor and arginine vasopressin mRNAs and facilitates stress-induced neuronal activation.

Guoliang Yu1, Hao Chen, Wenyuan Zhao, Shannon G Matta, Burt M Sharp.   

Abstract

Acute nicotine is a potent stimulus for activation of the stress-responsive hypothalamic-pituitary-adrenal (HPA) axis, while chronic nicotine self-administration (SA) desensitizes the ACTH response to self-administered nicotine but cross-sensitizes to mild footshock stress (mFSS). To identify underlying mechanisms, we investigated (1) the effects of chronic nicotine SA on the coexpression of corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) mRNAs, the primary hypothalamic neuropeptides regulating ACTH release, in the parvocellular division of paraventricular nucleus (pcPVN), and (2) mFSS-induced activation of these neurons during nicotine SA. Adult male Sprague Dawley rats were given 23 h/d unlimited access to self-administer nicotine (0.03 mg/kg per injection, i.v.) for 19 d. Brains were double labeled with fluorescence in situ hybridization of CRF and AVP mRNAs and triple labeled after mFSS exposure for CRF and AVP mRNAs and c-Fos protein. Chronic nicotine SA significantly increased AVP mRNA signal and the number of pcPVN AVP-positive (AVP(+)) neurons (twofold to threefold), reduced the number of CRF-positive (CRF(+)) neurons by approximately 60%, but increased pcPVN CRF(+)/AVP(+) neuronal number fivefold. Significantly, although chronic nicotine SA did not affect total c-Fos expression induced by mFSS in pcPVN CRF(+) neurons, the majority of the new CRF(+)/AVP(+) population was activated by this heterotypic stressor. These phenotypic neuronal alterations may provide the pivotal mechanism underlying the capacity of chronically self-administered nicotine to cross-sensitize the HPA response to specific stressors, suggesting that nicotine may augment HPA responsiveness to specific stressors in human smokers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18337407      PMCID: PMC6670662          DOI: 10.1523/JNEUROSCI.3837-07.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  16 in total

1.  Sexually diergic, dose-dependent hypothalamic-pituitary-adrenal axis responses to nicotine in a dynamic in vitro perfusion system.

Authors:  Jessica M McKlveen; Jared M Wilson; Robert T Rubin; Michael E Rhodes
Journal:  J Pharmacol Toxicol Methods       Date:  2010-02-01       Impact factor: 1.950

Review 2.  Substance use modulates stress reactivity: Behavioral and physiological outcomes.

Authors:  Anne Q Fosnocht; Lisa A Briand
Journal:  Physiol Behav       Date:  2016-02-19

3.  Nicotine self-administration diminishes stress-induced norepinephrine secretion but augments adrenergic-responsiveness in the hypothalamic paraventricular nucleus and enhances adrenocorticotropic hormone and corticosterone release.

Authors:  Guoliang Yu; Burt M Sharp
Journal:  J Neurochem       Date:  2009-12-17       Impact factor: 5.372

4.  Altered hypothalamic response to food in smokers.

Authors:  Paul Y Geha; Katja Aschenbrenner; Jennifer Felsted; Stephanie S O'Malley; Dana M Small
Journal:  Am J Clin Nutr       Date:  2012-12-12       Impact factor: 7.045

Review 5.  The Sociopharmacology of Tobacco Addiction: Implications for Understanding Health Disparities.

Authors:  Adam M Leventhal
Journal:  Nicotine Tob Res       Date:  2015-04-18       Impact factor: 4.244

6.  Nicotine self-administration differentially modulates glutamate and GABA transmission in hypothalamic paraventricular nucleus to enhance the hypothalamic-pituitary-adrenal response to stress.

Authors:  Guoliang Yu; Hao Chen; Xingjun Wu; Shannon G Matta; Burt M Sharp
Journal:  J Neurochem       Date:  2010-02-25       Impact factor: 5.372

7.  Sexually diergic hypothalamic-pituitary-adrenal (HPA) responses to single-dose nicotine, continuous nicotine infusion, and nicotine withdrawal by mecamylamine in rats.

Authors:  Natalie E Gentile; Julie D Andrekanic; Tracy E Karwoski; R Kenneth Czambel; Robert T Rubin; Michael E Rhodes
Journal:  Brain Res Bull       Date:  2011-03-17       Impact factor: 4.077

Review 8.  Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice.

Authors:  Christie D Fowler; Michael A Arends; Paul J Kenny
Journal:  Behav Pharmacol       Date:  2008-09       Impact factor: 2.293

9.  Sex-influence of nicotine and nitric oxide on motor coordination and anxiety-related neurophysiological responses.

Authors:  Rodrigo Muñoz-Castañeda; David Díaz; Carmelo A Avila-Zarza; José R Alonso; Eduardo Weruaga
Journal:  Psychopharmacology (Berl)       Date:  2013-10-01       Impact factor: 4.530

Review 10.  Role of corticotropin-releasing factor in alcohol and nicotine addiction.

Authors:  Sierra Simpson; Kokila Shankar; Adam Kimbrough; Olivier George
Journal:  Brain Res       Date:  2020-04-21       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.